Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity
about
NorovirusAdvances in norovirus biologyFlexibility in Surface-Exposed Loops in a Virus Capsid Mediates Escape from Antibody NeutralizationComplete nucleotide sequence of a norovirus GII.4 genotype: evidence for the spread of the newly emerged pandemic Sydney 2012 strain to China.The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.What is the reservoir of emergent human norovirus strains?Comparative genome analysis of a norovirus GII.4 strain GZ2013-L10 isolated from South China.A Multi-Site Study of Norovirus Molecular Epidemiology in Australia and New Zealand, 2013-2014.Transcriptomic analysis of human norovirus NS1-2 protein highlights a multifunctional role in murine monocytesOccurrence of novel GII.17 and GII.21 norovirus variants in the coastal environment of South Korea in 2015.Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.The state of norovirus vaccines.Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Within-host evolution results in antigenically distinct GII.4 norovirusesGenetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant VirusesDetection of circulating norovirus genotypes: hitting a moving targetParticle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.Pathogen evolution and the immunological niche.Norovirus in healthcare settings.Epidemiology of human noroviruses and updates on vaccine developmentEmergence of the GII-4 Norovirus Sydney2012 strain in England, winter 2012-2013.Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trialSerum Immunoglobulin A Cross-Strain Blockade of Human NorovirusesSerological Correlates of Protection against a GII.4 Norovirus.Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity.The transmissibility of noroviruses: Statistical modeling of outbreak events with known route of transmission in Japan.Burden of norovirus in healthcare facilities and strategies for outbreak control.Outbreak of Norovirus GII.P17-GII.17 in the Canadian Province of Nova Scotia.Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.The effect of malnutrition on norovirus infectionThe molecular pathology of noroviruses.Human Norovirus Evolution in a Chronically Infected Host.Noroviruses: epidemiology, immunity and prospects for prevention.Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.Methods for ascertaining norovirus disease burdens.Chronic norovirus infection and common variable immunodeficiency.Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses.
P2860
Q26864280-F67295B6-78A2-403F-9EE0-AB0AA2B16434Q27016152-5B179FE5-8298-41A6-BAAD-81DA2BB9C76CQ27681611-7C07D4E1-74DE-41D7-9F88-4E0A71EF252BQ30356098-C16BA93F-01B3-4A72-9533-C4B13DA4CBB5Q30358747-FE11DA1A-ECB3-4638-8FFF-4F7D846A5878Q30372827-00E9F740-15FA-4FE5-A398-DB6ED36666A5Q30383126-EDDE9040-8800-488D-A9CE-6D1D2044DD4FQ30387370-5E56B18C-D08A-42AC-97D6-59FB8DC65D08Q30397112-380F7F88-BBDB-4D3E-A2B2-D6217A1161DBQ30398627-A0503C16-6BBF-4A36-AAA5-6FEA0E856065Q30401642-51EB1185-01A8-4FA4-8A79-7D9F41B9E126Q33678125-7FB88486-9C0C-4949-B2EE-2016A2FD138EQ33743992-91046005-1929-4DFE-84D6-EA417E7BEB7BQ33744124-D354F83E-3F5A-4968-B6B7-3A3CA29FB018Q33832855-A3A61203-F94F-4E11-9830-31FF088B844AQ33959255-88CAD81F-6608-47B2-A584-A99D03CCE87BQ34059136-91989783-3E77-4370-835F-74701BC8D7E5Q34059409-0B208768-9076-41DC-8781-FD6DDCF7EB79Q34078369-1D8DEEC7-F15F-4CDE-9C14-B2D112A899D6Q34134280-EA55C027-C3B0-47DD-A4A0-DC454AB5C5E2Q34385139-D72F4FC6-6C2F-4A24-9B52-63A4AB1BC5E9Q35097664-52FAE3FD-1AD0-452F-BA76-039700310F03Q35212408-16E4E4DB-D5A7-4C84-BEED-0316377661FAQ35837799-8245ED4E-BDC5-4C14-953D-AA6753061939Q35901978-EDFA9703-5B1B-4AF0-9943-E851C2AF6BE3Q36254157-122C64C4-CAC1-4861-ADA5-2987BFF1BF56Q36309228-33F3AEC0-1F9F-42D5-8740-E020CCD9C3C9Q36344240-E48CC8B2-80A2-4569-B60B-F8AD591ED534Q36996869-BBA67A54-31F0-4DF2-8D46-8E6DFFB22A92Q37546555-933A4F05-BE95-450E-82C1-60C81CCF0F29Q37547547-1E4895FB-997D-4D4D-B059-A804396F74A2Q37645071-9C891641-3D2F-4BAC-80CE-BC98CB1DDC68Q38259875-CB3BDB0E-241A-46E3-9A86-7C5D68BCE53AQ38288362-BEB0D473-1CE4-47B4-8D3E-9C7CA6DE3531Q38322750-CFACE9D3-D502-4DF6-A1A2-BECCD0663D0CQ38374766-11FC1636-4725-4FDD-8940-398E3EEAB88EQ38557262-3C70EFA5-AB5A-4F37-A42F-1087384C68BBQ38869777-C5ADB6EF-2D95-4E0E-A4B8-CCF6F84B2109Q38983652-6C95B016-1931-4CE4-9A40-05CAF6C6E521Q39604515-6D1BAD14-1790-4808-A8F3-86CAF81C49FB
P2860
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Emergence of new pandemic GII. ...... with escape from herd immunity
@ast
Emergence of new pandemic GII. ...... with escape from herd immunity
@en
type
label
Emergence of new pandemic GII. ...... with escape from herd immunity
@ast
Emergence of new pandemic GII. ...... with escape from herd immunity
@en
prefLabel
Emergence of new pandemic GII. ...... with escape from herd immunity
@ast
Emergence of new pandemic GII. ...... with escape from herd immunity
@en
P2093
P2860
P50
P921
P356
P1476
Emergence of new pandemic GII. ...... with escape from herd immunity
@en
P2093
Davide Corti
Eric F Donaldson
Jesica Swanstrom
Lisa C Lindesmith
P2860
P304
P356
10.1093/INFDIS/JIT370
P407
P577
2013-08-01T00:00:00Z